Rapid up-regulation of cyclo-oxygenase 2 (COX-2) by 5-fluoruracil (5-FU) in human solid tumours

Autor: Di Nicolantonio, F., Mercer, S., Knight, La, Gabriel, Fg, Whitehouse, Pa, Sharma, S., Fernando, A., Bhandari, P., Somers, Ss, Simon Khay Chuan Toh, Cree, Ia

Publikováno v: Publons

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8994350444affcf3df8cb79504549df1
http://hdl.handle.net/2318/1519415

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC).

Autor: Glaysher S, Yiannakis D, Gabriel FG, Johnson P, Polak ME, Knight LA, Goldthorpe Z, Peregrin K, Gyi M, Modi P, Rahamim J, Smith ME, Amer K, Addis B, Poole M, Narayanan A, Gulliford TJ, Andreotti PE, Cree IA, Glaysher, Sharon

Publikováno v: BMC Cancer; 2009, Vol. 9, p300-300, 1p

Oxidation-sensitive cysteines drive IL-38 amyloid formation.

Autor: Diaz-Barreiro A; Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland. Electronic address: alejandro.diazbarreiro@unige.ch., Cereghetti G; Department of Chemistry, University of Cambridge, Cambridge, UK., Ortega Sánchez FG; IBS Granada, Institute of Biomedical Research, Granada, Spain; Pulmonology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain., Tonacini J; Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland., Talabot-Ayer D; Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland., Kieffer-Jaquinod S; Université Grenoble Alpes, CEA, INSERM, UA13 BGE, CNRS, CEA, FR2048 Grenoble, France., Kissling VM; Particles-Biology Interactions Laboratory, Department of Materials Meet Life, Empa (Swiss Federal Laboratories for Materials Science and Technology), St. Gallen, Switzerland., Huard A; Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland., Swale C; Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions and Immunity to Infection, University Grenoble Alpes, INSERM U1209, CNRS UMR5309, Grenoble, France., Knowles TPJ; Department of Chemistry, University of Cambridge, Cambridge, UK., Couté Y; Université Grenoble Alpes, CEA, INSERM, UA13 BGE, CNRS, CEA, FR2048 Grenoble, France., Peter M; Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland., Francés-Monerris A; Institut de Ciència Molecular, Universitat de València, 46071 València, Spain., Palmer G; Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Geneva Centre for Inflammation Research, Geneva, Switzerland.

Publikováno v: Cell reports [Cell Rep] 2024 Nov 01; Vol. 43 (11), pp. 114940. Date of Electronic Publication: 2024 Nov 01.